Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

University of Toronto

$194,990.00

Screening technologies for identification of bacterial vascular dissemination inhibitors and testing of novel antibioticcomplementing therapeutic molecules

FY 2014-15

Summary
The spread of bacteria from the initial site of infection to other parts of the body via the bloodstream (dissemination) isresponsible for most of the mortality caused by bacterial infection. Infectious diseases cost the Canadian economy$3.49B/year. The Canadian biopharmaceutical industry, Industry Canada and CIHR have identified discovery anddevelopment of novel classes of antibacterials and molecules for complementing the action of existing antibiotics as astrategic focus for Canadian innovation and development. Disrupting bacterial dissemination may provide an importantantibiotic-complementing approach for limiting infectious disease progression. The proposed project will develop rapid, lesscostly methods for identifying and characterizing bacterial dissemination inhibitors with potential use as novel treatments forbacterial infections.
Program
Collaborative Health Research Projects
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
446650-2013
Name nom
Moriarty, Tara
Department département
Dentistry, Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
194990
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2 & 3
Nb partie
3
Application title
Screening technologies for identification of bacterial vascular dissemination inhibitors and testing of novel antibioticcomplementing therapeutic molecules
Keyword
NSERC
Application summary
The spread of bacteria from the initial site of infection to other parts of the body via the bloodstream (dissemination) isresponsible for most of the mortality caused by bacterial infection. Infectious diseases cost the Canadian economy$3.49B/year. The Canadian biopharmaceutical industry, Industry Canada and CIHR have identified discovery anddevelopment of novel classes of antibacterials and molecules for complementing the action of existing antibiotics as astrategic focus for Canadian innovation and development. Disrupting bacterial dissemination may provide an importantantibiotic-complementing approach for limiting infectious disease progression. The proposed project will develop rapid, lesscostly methods for identifying and characterizing bacterial dissemination inhibitors with potential use as novel treatments forbacterial infections.
University of Toronto - $194,990 Grant (2014-15) | Canada Spends